A comprehensive view of Weight Issues. This page highlights a small sample of our full coverage.
For real-time access, please log in to your Consumer Wellness Market Intelligence Service.

Recent Articles

sample of recent headlines, press releases and get more..

Eli Lilly lists Phase 2 interventional clinical trial to investigate weight management with LY3841136 compared with placebo in adult participants with obesity or overweight

Executive Perspective: Nestle working on products to accompany weight-loss drugs like Ozempic, Wegovy and Mounjaro, as the food industry evolves in response to the soaring popularity of the appetite-killing drugs, says CEO Mark Schneider

Commentary: Action on Sugar’s recent call for a ban on child-orientated packaging on cereal is a call for creeping regulatory overreach to accelerate, ignores the science around weight loss, represents a slippery slope toward complete brand erosion

Goldman Sachs sees obesity dragging world GDP down by US$4T in 2035, but weight-loss drugs could change that; Novo Nordisk study finds Wegovy reduced chance of heart attacks, strokes and cardiovascular deaths by 20%, could help with sleep apnea, addiction

Commentary: Despite popularity of weight loss drugs, US retailers see minimal profit due to low gross margins on branded medications; while increased foot traffic could lead to multiple purchases for Walmart, impact varies for Rite Aid, CVS and Walgreens

Ask us about our Consumer Wellness market view

Trending Chart

Interactive chart with headline count